These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 19926618

  • 1. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ.
    Gut; 2010 Feb; 59(2):227-35. PubMed ID: 19926618
    [Abstract] [Full Text] [Related]

  • 2. IL-6-induced DNMT1 activity mediates SOCS3 promoter hypermethylation in ulcerative colitis-related colorectal cancer.
    Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.
    Carcinogenesis; 2012 Oct; 33(10):1889-96. PubMed ID: 22739025
    [Abstract] [Full Text] [Related]

  • 3. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis.
    Yu LZ, Wang HY, Yang SP, Yuan ZP, Xu FY, Sun C, Shi RH.
    World J Gastroenterol; 2013 May 07; 19(17):2638-49. PubMed ID: 23674871
    [Abstract] [Full Text] [Related]

  • 4. High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission.
    Xu AT, Li Y, Zhao D, Shen J, Xu XT, Qiao YQ, Zhu MM, Wang TR, Cui Y, Ai LY, Ran ZH.
    Inflamm Bowel Dis; 2015 Feb 07; 21(2):241-50. PubMed ID: 25545374
    [Abstract] [Full Text] [Related]

  • 5. Dysregulation of IL6/IL6R-STAT3-SOCS3 signaling pathway in IBD-associated colorectal dysplastic lesions as compared to sporadic colorectal adenomas in non-IBD patients.
    Gui X, Iacucci M, Ghosh S.
    Pathol Res Pract; 2020 Nov 07; 216(11):153211. PubMed ID: 32979687
    [Abstract] [Full Text] [Related]

  • 6. Qing Hua Chang Yin inhibits the LPS-induced activation of the IL-6/STAT3 signaling pathway in human intestinal Caco-2 cells.
    Ke X, Hu G, Fang W, Chen J, Zhang X, Yang C, Peng J, Chen Y, Sferra TJ.
    Int J Mol Med; 2015 Apr 07; 35(4):1133-7. PubMed ID: 25633437
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA214 Is Associated With Progression of Ulcerative Colitis, and Inhibition Reduces Development of Colitis and Colitis-Associated Cancer in Mice.
    Polytarchou C, Hommes DW, Palumbo T, Hatziapostolou M, Koutsioumpa M, Koukos G, van der Meulen-de Jong AE, Oikonomopoulos A, van Deen WK, Vorvis C, Serebrennikova OB, Birli E, Choi J, Chang L, Anton PA, Tsichlis PN, Pothoulakis C, Verspaget HW, Iliopoulos D.
    Gastroenterology; 2015 Oct 07; 149(4):981-92.e11. PubMed ID: 26055138
    [Abstract] [Full Text] [Related]

  • 8. Increased suppressor of cytokine signaling-3 expression predicts mucosal relapse in ulcerative colitis.
    Li Y, Nuij VJ, Baars JE, Biermann K, Kuipers EJ, Peppelenbosch MP, de Haar C, Janneke van der Woude C.
    Inflamm Bowel Dis; 2013 Jan 07; 19(1):132-40. PubMed ID: 22535619
    [Abstract] [Full Text] [Related]

  • 9. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U.
    J Crohns Colitis; 2013 Dec 07; 7(12):968-73. PubMed ID: 23433613
    [Abstract] [Full Text] [Related]

  • 10. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M, Ishikawa T, Ishiguro M, Tokura M, Yamauchi S, Kikuchi A, Uetake H, Yasuno M, Kawano T.
    J Gastroenterol; 2018 May 07; 53(5):631-641. PubMed ID: 28884228
    [Abstract] [Full Text] [Related]

  • 11. IL-6/STAT3/SOCS3 signaling pathway playing a regulatory role in ulcerative colitis carcinogenesis.
    Chen YY, Ma ZB, Xu HY, Shi LJ, Li DY, Sun LY, Yin XH, Sang GY, Xu D, Tang YH, Wang X, Li P, Wu F, Zhou J.
    Int J Clin Exp Med; 2015 May 07; 8(8):12009-17. PubMed ID: 26550113
    [Abstract] [Full Text] [Related]

  • 12. STAT1, STAT6 and adenosine 3',5'-cyclic monophosphate (cAMP) signaling drive SOCS3 expression in inactive ulcerative colitis.
    Li Y, Deuring J, Peppelenbosch MP, Kuipers EJ, de Haar C, van der Woude CJ.
    Mol Med; 2012 Dec 20; 18(1):1412-9. PubMed ID: 23154639
    [Abstract] [Full Text] [Related]

  • 13. Clinical significance of mucosal suppressors of cytokine signaling 3 expression in ulcerative colitis.
    Miyanaka Y, Ueno Y, Tanaka S, Yoshioka K, Hatakeyama T, Shimamoto M, Sumii M, Chayama K.
    World J Gastroenterol; 2007 Jun 07; 13(21):2939-44. PubMed ID: 17589943
    [Abstract] [Full Text] [Related]

  • 14. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M, Scarpa M, Castagliuolo I, Erroi F, Kotsafti A, Basato S, Brun P, D'Incà R, Rugge M, Angriman I, Castoro C.
    Oncotarget; 2016 Mar 01; 7(9):10322-31. PubMed ID: 26862732
    [Abstract] [Full Text] [Related]

  • 15. Up-regulation of mitochondrial chaperone TRAP1 in ulcerative colitis associated colorectal cancer.
    Chen R, Pan S, Lai K, Lai LA, Crispin DA, Bronner MP, Brentnall TA.
    World J Gastroenterol; 2014 Dec 07; 20(45):17037-48. PubMed ID: 25493016
    [Abstract] [Full Text] [Related]

  • 16. IL-9 promotes the pathogenesis of ulcerative colitis through STAT3/SOCS3 signaling.
    Tian L, Li Y, Zhang J, Chang R, Li J, Huo L.
    Biosci Rep; 2018 Dec 21; 38(6):. PubMed ID: 30369485
    [Abstract] [Full Text] [Related]

  • 17. Shift from pStat6 to pStat3 predominance is associated with inflammatory bowel disease-associated dysplasia.
    Wick EC, LeBlanc RE, Ortega G, Robinson C, Platz E, Pardoll DM, Iacobuzio-Donahue C, Sears CL.
    Inflamm Bowel Dis; 2012 Jul 21; 18(7):1267-74. PubMed ID: 22021169
    [Abstract] [Full Text] [Related]

  • 18. Pien Tze Huang ameliorates DSS‑induced colonic inflammation in a mouse colitis model through inhibition of the IL‑6/STAT3 pathway.
    Li L, Shen A, Chu J, Sferra TJ, Sankararaman S, Ke X, Chen Y, Peng J.
    Mol Med Rep; 2018 Jul 21; 18(1):1113-1119. PubMed ID: 29845215
    [Abstract] [Full Text] [Related]

  • 19. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 21; 7(12):e684-91. PubMed ID: 23916526
    [Abstract] [Full Text] [Related]

  • 20. EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients.
    Srivatsa S, Paul MC, Cardone C, Holcmann M, Amberg N, Pathria P, Diamanti MA, Linder M, Timelthaler G, Dienes HP, Kenner L, Wrba F, Prager GW, Rose-John S, Eferl R, Liguori G, Botti G, Martinelli E, Greten FR, Ciardiello F, Sibilia M.
    Gastroenterology; 2017 Jul 21; 153(1):178-190.e10. PubMed ID: 28400195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.